Stockholders' Equity - Schedule of Stockholders' Equity (Details) - USD ($) shares in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance of shares outstanding, beginning of period (in shares)	157,013
Balance, beginning of period	$ 774,357,000	$ 1,139,558,000
Non-cash share-based compensation	1,124,000	2,762,000
Purchase of treasury stock at cost		(112,874,000)
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding	(447,000)	10,722,000
Equitable adjustments to stock-based awards	(13,000)
Change in noncontrolling interests	(124,000)	(189,000)
Net loss	(26,762,000)	(44,680,000)
Foreign currency translation adjustment, net of tax of $0	72,797,000	49,575,000
Minimum pension liability adjustment, net of tax of $0	$ 0	14,000
Balance of shares outstanding, end of period (in shares)	157,174
Balance, end of period	$ 820,932,000	1,044,888,000
Foreign currency translation adjustment, tax	0	0
Pension adjustment, tax	$ 0	0
Common stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance of shares outstanding, beginning of period (in shares)	157,013
Balance, beginning of period	$ 923,000
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding (in shares)	161
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding	$ 1,000
Balance of shares outstanding, end of period (in shares)	157,174
Balance, end of period	$ 924,000
Additional paid-in capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period	2,204,755,000	2,388,783,000
Non-cash share-based compensation	1,124,000	2,762,000
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding	(448,000)	10,716,000
Equitable adjustments to stock-based awards	(13,000)
Change in noncontrolling interests	16,000	(189,000)
Balance, end of period	2,205,434,000	2,402,072,000
Retained earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period	39,244,000	15,523,000
Net loss	(26,607,000)	(44,211,000)
Balance, end of period	12,637,000	(28,688,000)
Accumulated other comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period	(442,424,000)	(520,204,000)
Foreign currency translation adjustment, net of tax of $0	72,791,000	49,573,000
Minimum pension liability adjustment, net of tax of $0		14,000
Balance, end of period	(369,633,000)	(470,617,000)
Treasury stock at cost
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period	(1,026,272,000)	(744,174,000)
Purchase of treasury stock at cost		(112,874,000)
Balance, end of period	(1,026,272,000)	(857,048,000)
Non-controlling interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period	(1,869,000)	(1,285,000)
Change in noncontrolling interests	(140,000)	0
Net loss	(155,000)	(469,000)
Foreign currency translation adjustment, net of tax of $0	6,000	2,000
Balance, end of period	$ (2,158,000)	$ (1,752,000)
Common stock | Common stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance of shares outstanding, beginning of period (in shares)		180,611
Balance, beginning of period		$ 915,000
Purchases of treasury stock at cost (in shares)		(9,485)
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding (in shares)		1,379
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding		$ 6,000
Balance of shares outstanding, end of period (in shares)		172,505
Balance, end of period		$ 921,000